These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15709920)

  • 1. Nitric oxide and the angiogenic response: can we improve the results of therapeutic angiogenesis?
    Kapila V; Sellke FW; Suuronen EJ; Mesana TG; Ruel M
    Expert Opin Investig Drugs; 2005 Jan; 14(1):37-44. PubMed ID: 15709920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimethylarginine dimethylaminohydrolase: a new therapeutic target for the modulation of nitric oxide and angiogenesis.
    Singh JP
    Curr Opin Investig Drugs; 2007 Sep; 8(9):736-41. PubMed ID: 17729185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of L-arginine on fibroblast growth factor 2-induced angiogenesis in a model of endothelial dysfunction.
    Voisine P; Li J; Bianchi C; Khan TA; Ruel M; Xu SH; Feng J; Rosinberg A; Malik T; Nakai Y; Sellke FW
    Circulation; 2005 Aug; 112(9 Suppl):I202-7. PubMed ID: 16159817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction--an obstacle of therapeutic angiogenesis.
    Sun L; Bai Y; Du G
    Ageing Res Rev; 2009 Oct; 8(4):306-13. PubMed ID: 19389489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism.
    Schgoer W; Theurl M; Jeschke J; Beer AG; Albrecht K; Gander R; Rong S; Vasiljevic D; Egger M; Wolf AM; Frauscher S; Koller B; Tancevski I; Patsch JR; Schratzberger P; Piza-Katzer H; Ritsch A; Bahlmann FH; Fischer-Colbrie R; Wolf D; Kirchmair R
    Circ Res; 2009 Nov; 105(10):994-1002. PubMed ID: 19797703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (2-Hydroxypropyl)-β-Cyclodextrin Is a New Angiogenic Molecule for Therapeutic Angiogenesis.
    Qi X; Yuan Y; Xu K; Zhong H; Zhang Z; Zhai H; Guan G; Yu G
    PLoS One; 2015; 10(5):e0125323. PubMed ID: 25944736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of simvastatin and/or antioxidant vitamins in therapeutic angiogenesis in experimental diabetic hindlimb ischemia: effects on capillary density, angiogenesis markers, and oxidative stress.
    El-Azab MF; Hazem RM; Moustafa YM
    Eur J Pharmacol; 2012 Sep; 690(1-3):31-41. PubMed ID: 22705060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Promotes Angiogenesis and Ischemia-Induced Neovascularization Via NADPH Oxidase 4 (NOX4) and Nitric Oxide-Dependent Mechanisms.
    Di Bartolo BA; Cartland SP; Prado-Lourenco L; Griffith TS; Gentile C; Ravindran J; Azahri NS; Thai T; Yeung AW; Thomas SR; Kavurma MM
    J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26572549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide.
    Babaei S; Teichert-Kuliszewska K; Zhang Q; Jones N; Dumont DJ; Stewart DJ
    Am J Pathol; 2003 Jun; 162(6):1927-36. PubMed ID: 12759249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines.
    Losordo DW; Dimmeler S
    Circulation; 2004 Jun; 109(21):2487-91. PubMed ID: 15173038
    [No Abstract]   [Full Text] [Related]  

  • 11. Low molecular-weight fucoidan protects against hindlimb ischemic injury in type 2 diabetic mice through enhancing endothelial nitric oxide synthase phosphorylation.
    Liu T; Wang Z; Chen X; You H; Xue J; Cai D; Zheng Y; Xu Y; Luo D
    J Diabetes; 2018 Nov; 10(11):820-834. PubMed ID: 29633569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combating cardiovascular disease with angiogenic therapy.
    Jacobs J
    Drug Discov Today; 2007 Dec; 12(23-24):1040-5. PubMed ID: 18061883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-based therapeutic angiogenesis.
    Yeh JL; Giordano FJ
    Semin Thorac Cardiovasc Surg; 2003 Jul; 15(3):236-49. PubMed ID: 12973701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current thoughts on angiogenesis.
    Chan LK
    J Wound Care; 2009 Jan; 18(1):12-4, 16. PubMed ID: 19131912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic angiogenesis in cardiovascular disease.
    Simons M; Ware JA
    Nat Rev Drug Discov; 2003 Nov; 2(11):863-71. PubMed ID: 14668807
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiogenesis: bench to bedside, have we learned anything?
    Lee SU; Wykrzykowska JJ; Laham RJ
    Toxicol Pathol; 2006; 34(1):3-10. PubMed ID: 16507538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necessity for re-vascularization after spinal cord injury and the search for potential therapeutic options.
    Graumann U; Ritz MF; Hausmann O
    Curr Neurovasc Res; 2011 Nov; 8(4):334-41. PubMed ID: 22023610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of therapeutic myocardial angiogenesis.
    Boodhwani M; Sodha NR; Laham RJ; Sellke FW
    Shock; 2006 Oct; 26(4):332-41. PubMed ID: 16980878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-Angiogenic Effects of Low Dose Ethoxidine in a Murine Model of Ischemic Hindlimb: Correlation between Ethoxidine Levels and Increased Activation of the Nitric Oxide Pathway.
    Clere N; To KHT; Legeay S; Bertrand S; Helesbeux JJ; Duval O; Faure S
    Molecules; 2017 Apr; 22(4):. PubMed ID: 28417947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane.
    Lazarovici P; Gazit A; Staniszewska I; Marcinkiewicz C; Lelkes PI
    Endothelium; 2006; 13(1):51-9. PubMed ID: 16885067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.